https://www.takeda.com/newsroom/newsreleases/2021/takeda-presents-positive-results-for-mobocertinib-in-patients-with-egfr-exon20-insertion-mnsclc-who-received-prior-platinum-based-chemotherapy/
Takeda Presents Positive Results for Mobocertinib in Patients with EGFR Exon20 Insertion+ mNSCLC who Received Prior Platinum-Based Chemotherapy
results fortakedapresentspositivemobocertinib